Building Supports for Perinatal Substance Use Disorder

Substance use during pregnancy and postpartum can seriously harm both parent and baby, heightening the risk of complications like preterm birth, stillbirth, neonatal withdrawal, and maternal overdose—especially during the high-risk postpartum period. Addressing perinatal substance use disorder (SUD) requires sustained, specialized care, as this period offers a vital opportunity to intervene, prevent relapse, and support lasting recovery.

Read the report, which explores substance use during pregnancy as a critical public health issue, examining the historical approach to treatment, the persistent stigma surrounding it, the urgent need for integrated care, and programs in Michigan that are addressing SUD.

Ashley Gray, a mother of three in Macomb County, shares her story of navigating substance use and mental health challenges. She began using substances at a young age and continued to struggle into adulthood, including during her pregnancies. Throughout her care, Ashley often felt dismissed or judged by medical professionals; stigma made it difficult to ask for help.

Hear Their Voices

“Mental health and substance abuse are so shunned and frowned upon, but they gave me so many opioids in the hospital. Then gave me eight NORCOs to go home, with severe mental health issues after having a traumatic experience. So [we need] more coordination of care, maybe a system where professionals can interact with each other more.”

Anonymous

Metro Detroit

Policy Recommendations

Since the report was published in 2022, Michigan has made initial strides in addressing perinatal SUD, primarily via Regional Perinatal Quality Collaboratives. In 2024, Michigan invested $1.3 million in opioid settlement funds to expand the “rooming-in” model, which keeps infants with their birthing parents after delivery. Additionally, Michigan has received over $109 million from the Substance Abuse and Mental Health Services Administration (SAMHSA) to support critical services.

However, a unified statewide strategy to address perinatal SUD remains absent. Critical gaps remain—especially in rural regions. Addressing these disparities will require sustained investment in regional equity, expanded access to treatment, and efforts to reduce stigma.

Key policy recommendations include:

Expand Medicaid

formulary and streamline prior authorization to ensure timely access to clinically appropriate dosing of medications for opioid use disorder. 

Expand perinatal models

to fund and scale integrated perinatal care models that co-locate medical, behavioral health, psychiatric, and social supports for individuals with SUD.

Educate providers

on the physiological changes during pregnancy and the postpartum period that elevate overdose risk—particularly after a period of abstinence.

Incorporate education

and training on stigma and bias for SUD for providers and other perinatal professionals. 

Take Action Today

View Fast Facts

See fast facts to understand the scope of need to support birthing people with substance use disorder.

Educate decision-makers

Read this advocacy primer to learn how to make a compelling case for supporting birthing people with substance use disorder and other issues you care about.